IMMUCELL (ICCC) director Kathy V. Turner files initial insider Form 3

Rhea-AI Filing Summary

IMMUCELL CORP /DE/ filed an initial Form 3 reporting that Kathy V. Turner is a director of the company. The filing does not list any equity holdings or report any transactions in the company’s securities, serving mainly as a baseline disclosure of insider status.

Key Figures

Reported buy transactions: 0 transactions Reported sell transactions: 0 transactions Net buy/sell shares: 0 shares

3 metrics

Reported buy transactions 0 transactions Form 3 transactionSummary buyCount

Reported sell transactions 0 transactions Form 3 transactionSummary sellCount

Net buy/sell shares 0 shares Form 3 transactionSummary netBuySellShares

Key Terms

Form 3, reporting person, beneficial ownership

3 terms

Form 3 regulatory

"filed an initial Form 3 reporting that Kathy V. Turner is a director"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"begin ongoing reporting of any future transactions under SEC rules"

beneficial ownership financial

"serves as an initial beneficial ownership statement"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Turner Kathy V

(Last) (First) (Middle)

C/O IMMUCELL CORPORATION

56 EVERGREEN DRIVE

(Street)

PORTLAND MAINE 04103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
IMMUCELL CORP /DE/ [ ICCC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Timothy C. Fiori Attorney-in-Fact	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the IMMUCELL (ICCC) Form 3 for Kathy V. Turner show?

The Form 3 identifies Kathy V. Turner as a director of IMMUCELL CORP /DE/. It serves as an initial beneficial ownership statement and, in this case, reports no transactions or specific share holdings in the company’s securities.

Are any IMMUCELL (ICCC) share transactions reported in this Form 3?

No transactions are reported in this Form 3. The transactionSummary shows zero buy, sell, acquire, dispose, gift, or tax-withholding entries, indicating this filing only establishes the insider’s status without recording trading activity.

Does the IMMUCELL (ICCC) Form 3 disclose how many shares Kathy V. Turner owns?

This Form 3 does not disclose any specific share count for Kathy V. Turner. The filing simply registers her as a director and initial reporting person, without listing common stock or derivative positions in the summarized data provided.

Why is IMMUCELL (ICCC) filing a Form 3 for Kathy V. Turner?

Form 3 is required when someone becomes an insider, such as a director, of a public company. IMMUCELL filed this Form 3 to formally disclose Kathy V. Turner’s insider status and begin ongoing reporting of any future transactions under SEC rules.

Does the IMMUCELL (ICCC) Form 3 mention any derivative securities for Kathy V. Turner?

No derivative securities are listed for Kathy V. Turner in this Form 3. The derivativeSummary section is empty, meaning no options, warrants, or other derivative positions are reported in the provided data excerpt.